课题基金 / 基金详情

项目摘要

项目成果

Thomas Denny的其他基金

相似基金

相关文献

中文摘要
翻译
CHAVI最终成功的关键是发展其快速移动新产品的能力
英文摘要
Critical to the ultimate success of the CHAVI is the development of its capacity to rapidly move new discoveries and acquired technologies to testing in preclinical / clinical trials through collaboration with existing networks such as the HVTN, VRC, CAVD/Enterprise, and the NIH. In Year 3, CHAVI will ask critical questions with the current best vectors and inserts regarding insert immunogenicity and quality of the mucosal and systemic immune responses. The CHAVI Vaccine Production Core will coordinate and manage timelines required for preclinical studies in year 3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2 - GMP Manufacturing of mRNA Immunogens
  • 批准号:
    10355429
  • 项目类别:
  • 资助金额:
    $643.28万
  • 财政年份:
    2019
  • 负责人:
    Thomas Denny
  • 依托单位:
IMMUNOLOGY QUALITY ASSESSMENT PROGRAM
  • 批准号:
    9528361
  • 项目类别:
  • 资助金额:
    $151.52万
  • 财政年份:
    2014
  • 负责人:
    Thomas Denny
  • 依托单位:
IMMUNOLOGY QUALITY ASSESSMENT PROGRAM
  • 批准号:
    8936676
  • 项目类别:
  • 资助金额:
    $137.9万
  • 财政年份:
    2014
  • 负责人:
    Thomas Denny
  • 依托单位:
IMMUNOLOGY QUALITY ASSESSMENT PROGRAM
  • 批准号:
    10189437
  • 项目类别:
  • 资助金额:
    $150.75万
  • 财政年份:
    2014
  • 负责人:
    Thomas Denny
  • 依托单位:
海外基金